VistaGen Therapeutics Inc logo

VistaGen Therapeutics Inc

$ 0.18 -0.0104 (-5.39%) 10:35 AM EST
P/E:
At Loss
P/B:
0.81
Market Cap:
$ 37.79M
Enterprise V:
$ -6.91M
Volume:
5.55M
Avg Vol (2M):
14.37M
Volume:
5.55M
Market Cap $:
37.79M
PE Ratio:
At Loss
Avg Vol (2-Month):
14.37M
Enterprise Value $:
-6.91M
PB Ratio:
0.81
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

VistaGen Therapeutics Inc Stock Institutional Ownership and Insider Ownership -

206.84
(Mil)
Shares Outstanding
25.68%
53.06 (Mil)
Institutional Ownership
0.29%
0.60 (Mil)
Insider Ownership
99.79%
206.4152 (Mil)
Float Percentage of TSO

Short Interest History (%)

Due to a license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus’ website, except for certain Australian stocks.

Institutional Ownership History (%)

This the Institutional Ownership History of VistaGen Therapeutics Inc. Peter Lynch prefers to buy companies with low institutional ownership.
EMBED
SAVE

Insider ownership (%)

This is the historical insider ownership of VistaGen Therapeutics Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.

Top Direct Holders

Top Fund Holders